|
|
| | Benzamide, 4-methoxy-N-[(3-oxocyclopentadecyl)methyl]- Basic information |
| | Benzamide, 4-methoxy-N-[(3-oxocyclopentadecyl)methyl]- Chemical Properties |
| Boiling point | 571.5±25.0 °C(predicted) | | density | 0.987±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 14.69±0.46(predicted) |
| | Benzamide, 4-methoxy-N-[(3-oxocyclopentadecyl)methyl]- Usage And Synthesis |
| Uses | ZM-32 is an inhibitor for human antigen R (HuR), that downregulates the expression of VEGF-A and MMP9, and thus inhibits breast cancer tumor angiogenesis. ZM-32 exhibits broad-spectrum anti-proliferative effects in a variety of cancer cell lines, and exhibits antitumor efficacy against MDA-MB-231 in mouse models[1]. | | References | [1] Yang LQ, et al., Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression. Biomed Pharmacother. 2021 Apr;136:111265. DOI:10.1016/j.biopha.2021.111265 |
| | Benzamide, 4-methoxy-N-[(3-oxocyclopentadecyl)methyl]- Preparation Products And Raw materials |
|